The competition heated up in the $71.5 billion global diabetes market last year after Indianapolis-based Eli Lilly’s and Boehringer Ingelheim’s Jardiance unexpectedly reduced the risk of heart attacks, strokes and deaths in a study.
State health officials are urging Indiana's health care providers to aggressively test patients for syphilis.
The state’s Family and Social Services Administration is set to cut home health care Medicaid reimbursements for licensed practical nurses, registered nurses, aides, therapists and pathologists.
Biochemist has founded or co-founded five startups since retiring from Eli Lilly and Co. as head of biotechnology research 13 years ago, at age 50.
The Indianapolis-based drugmaker said Tuesday it has built a robust pipeline of drugs that “has the potential” to launch 20 new products in the 10 years between 2014 and 2023.
A court-appointed patient care ombudsman who looked into Nightingale Home Healthcare’s operations says he found more than 1,300 complaints from patients and family members since 2011.
A Carmel surgery center is joining others in the state in suing UnitedHealthcare, alleging it unlawfully withheld payment for some services to make up for overpayment of other claims.
Indiana is one of several states involved in legal battles over the storage of blood samples. The cases pose a dilemma: How can society balance the right to privacy with the needs of science and medical research?
The founder of AIT Laboratories, along with his insurance companies and bank, will pay back more than $3 million to employees who bought the company from him six years ago at what the government said was an inflated price.
It’s been a roller-coaster ride for Indiana physicians and hospitals, with fees swinging wildly up and down in recent years to fund a state insurance program that helps pay malpractice awards.
The Indiana Blood Center said it has been forced to defer up to 30 percent of donors at some post-spring break blood drives because they had traveled to areas where the Zika virus is being transmitted.
A federal judge made the award to Lilly’s former executive director of human resources, who quit for health reasons and was later dropped from the company’s extended disability plan.
Deep cuts in Medicare reimbursements and competition from a few huge national chains and walk-in labs are making it tougher for Indianapolis-based AIT and other toxicology labs to compete.
Indianapolis-based chemical manufacturer Vertellus Specialties Inc. has expanded its production capacity by 80 percent to keep up with customer demand for DEET, a common active ingredient in mosquito and tick repellents.
It’s the largest recall in recent years for Cook, which previously had issued four recalls covering more than 400,000 catheters and pressuring monitoring sets in the past two years.
The Indianapolis-based insurer essentially broke even on its Obamacare exchange business last year.
The company, which is in the process of buying rival insurer Cigna Corp. for $54 billion, said medical enrollment has climbed by about 1 million members since the end of 2015, reaching 39.6 million members.
Bristol-Myers Squibb Co.’s blockbuster cancer drug Opdivo prolonged survival in cases of recurrent head and neck cancer, a first for patients with the harshest form of the disease who often face a bleak prognosis.
UnitedHealth Group Inc., the biggest U.S. health insurer, said it expects to lose about $650 million on the Obamacare plans this year.
On July 1, Indiana will join 46 states in allowing physicians to write prescriptions after talking to patients on their laptops or smartphones, with no office visit required.
